003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,990.00
−1.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.80x
- P/E 2027E
- 9.79x
- P/E 2028E
- 9.20x
- P/S forward
- 0.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- 65.18x
- PEG TTM
- —
- Price / book
- 0.64x
- Price / sales
- 0.28x
- Price / cash flow
- 6.81x
Enterprise value
- Enterprise value
- KRW 302.4B
- EV / sales
- 0.49x
- EV / EBITDA
- -7.38x
- EV / EBIT
- -4531.60x
- Market cap
- KRW 171.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026